Air Canada (TSX:AC) Stock Is Lifting off Despite a Gloomy Q3

Air Canada (TSX:AC) soared on Monday despite posting a huge loss as Pfizer revealed its Covid-19 vaccine is 90% effective.

| More on:
Airport and plane

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Air Canada posted its third consecutive quarterly loss on Monday, as the COVID-19 pandemic crippled air travel forcing Canada’s largest airline to cut the majority of its flights.

International air travel remains severely affected around the world due to border restrictions imposed by many countries.

As a result, carriers, including Air Canada, have cut thousands of jobs to cut costs and asked for government help to keep their operations afloat.

Air Canada Q3 results are as gloomy as can be expected

Air Canada reported a third-quarter net loss of $685 million on Monday, compared to a gain of $636 million at the same time last year.

The airline says the loss was $2.31 per diluted share, compared with earnings of $2.35 per diluted share in the third quarter of 2019.

Operating revenue for the quarter plunged about 86% to $757 million, down from $5.53 billion reported in the same quarter last year. Small consolation, its freight transportation revenues jumped 52% to $269 million.

Analysts on average expected Air Canada to lose $2.60 per share in the third quarter on revenue of $1.06 billion, according to IBES data from Refinitiv.

The airline says net cash burn for the quarter totalled $818 million, or about $9 million, significantly better than its forecast, which was between $1.35 and $1.6 billion or between $15 and $17 million a day.

Air Canada says the total number of passengers carried during the quarter decreased by 88% compared to a year ago.

The carrier expects to reduce its capacity in the fourth quarter by approximately 75% from the fourth quarter of 2019.

The airline cancels 12 Airbus A220 and 10 737 MAX orders

Still deprived of 86% of its revenue, Air Canada cancelled 12 orders for A220 aircraft manufactured in Mirabel but is suspending cancellations of regional flights pending the outcome of its discussions with Ottawa.

Cancellations represent nearly a quarter from 45 A220-300s ordered by Air Canada, which also eliminates 10 Boeing 737 MAX 8 aircraft from its book. Deliveries scheduled for 2021 and 2022 are also postponed.

A total of 95 domestic, transborder and international lines, as well as nine Canadian stopovers that the carrier claims to have identified as needing to be closed to preserve its liquidity, will also be maintained “…given the public statements made by the Honourable Marc Garneau, Canada’s Minister of Transport, on November 8, 2020, regarding commencing immediate discussions with major airlines on aviation industry sector-specific support”.

Marc Garneau said in a statement: “We are ready to establish a process with major airlines regarding financial assistance which could include loans and potentially other support to secure important results for Canadians. We anticipate beginning discussions with them this week.”

New federal support for the airline industry will depend on carriers reimbursing passengers whose flights have been cancelled.

Why Air Canada stock is soaring

Air Canada stock soared by 25% to $19.70 shortly after the opening bell on Monday. The big surge in price is due to an announcement by Pfizer that its COVID-19 vaccine may be 90% effective. Airlines and other cyclical stocks soared after the news. An effective vaccine will be beneficial for Air Canada as passengers will want to travel again. Having lost almost two-thirds of their value year-to-date, Air Canada shares are cheap.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf has no position in any of the stocks mentioned.

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »